GF
TRML

Gabelli Funds’s Tourmaline Bio TRML Stock Holding History

Gabelli Funds’s Portfolio TRML Stock Details TRML Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-119,850
Closed -$5.73M – 1298
2025
Q3 		$5.73M Buy
+119,850
New +$3.32M 0.04% 455

Gabelli Funds's TRML Position: Q4 2025 in Review

Gabelli Funds sold out of Tourmaline Bio (TRML) in Q4 2025, closing a stake of 119,850 shares — an estimated $5.73M sold.

Gabelli Funds first reported a position in TRML in Q3 2025 and held it in 1 quarter. The position peaked at $5.73M in Q3 2025. 0 funds tracked by Wall St. Rank hold TRML as of Q4 2025.

  • Gabelli Funds reported no remaining Tourmaline Bio position as of Q4 2025 after selling out during the quarter.
  • Gabelli Funds sold 119,850 Tourmaline Bio shares in Q4 2025, an estimated $5.73M.
  • Gabelli Funds first reported a position in Tourmaline Bio in Q3 2025 and held it in 1 quarter.
  • Gabelli Funds's Tourmaline Bio position peaked at $5.73M in Q3 2025.
  • 0 funds tracked by Wall St. Rank held Tourmaline Bio as of Q4 2025.

Based on Gabelli Funds's 13F filing for Q4 2025, filed 5 Feb 2026.